-
Something wrong with this record ?
Optimal Target Range of Closed-Loop Inspired Oxygen Support in Preterm Infants: A Randomized Cross-Over Study
MEN. van den Heuvel, HA. van Zanten, TE. Bachman, AB. Te Pas, AH. van Kaam, W. Onland,
Language English Country United States
Document type Journal Article, Multicenter Study, Randomized Controlled Trial
- MeSH
- Time Factors MeSH
- Intensive Care Units, Neonatal MeSH
- Clinical Alarms statistics & numerical data MeSH
- Cross-Over Studies MeSH
- Oxygen blood MeSH
- Humans MeSH
- Noninvasive Ventilation methods MeSH
- Infant, Premature MeSH
- Infant, Newborn MeSH
- Oximetry methods MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Infant, Newborn MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Randomized Controlled Trial MeSH
- Geographicals
- Netherlands MeSH
OBJECTIVE: To investigate the effect of different pulse oximetry (SpO2) target range settings during automated fraction of inspired oxygen control (A-FiO2) on time spent within a clinically set SpO2 alarm range in oxygen-dependent infants on noninvasive respiratory support. STUDY DESIGN: Forty-one preterm infants (gestational age [median] 26 weeks, age [median] 21 days) on FiO2 >0.21 receiving noninvasive respiratory support were subjected to A-FiO2 using 3 SpO2 target ranges (86%-94%, 88%-92%, or 89%-91%) in random order for 24 hours each. Before switching to the next target range, SpO2 was manually controlled for 24 hours (washout period). The primary outcome was the time spent within the clinically set alarm limits of 86%-94%. RESULTS: The percent time within the 86%-94% SpO2 alarm range was similar for all 3 A-FiO2 target ranges (74%). Time spent in hyperoxemia was not significantly different between target ranges. However, the time spent in severe hypoxemia (SpO2 <80%) was significantly reduced during the narrowed target ranges of A-FiO2 (88%-92%; 1.9%, 89%-91%; 1.7%) compared with the wide target range (86%-94%; 3.4%, P < .001). There were no differences between the 88%-92% and 89-91% target range. CONCLUSIONS: Narrowing the target range of A-FiO2 to the desired median ±2% is effective in reducing the time spent in hypoxemia, without increasing the risk of hyperoxemia. TRIAL REGISTRATION: www.trialregister.nl: NTR4368.
Department of Neonatology Emma Children's Hospital Academic Medical Center Amsterdam The Netherlands
Faculty of Biomedical Engineering Czech Technical University Prague Kladno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012760
- 003
- CZ-PrNML
- 005
- 20190416074955.0
- 007
- ta
- 008
- 190405s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jpeds.2018.01.077 $2 doi
- 035 __
- $a (PubMed)29571932
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a van den Heuvel, Maria Elisabeth Nicoletta $u Department of Neonatology, Emma Children's Hospital, Academic Medical Center Amsterdam, The Netherlands. Electronic address: m.e.vandenheuvel@amc.uva.nl.
- 245 10
- $a Optimal Target Range of Closed-Loop Inspired Oxygen Support in Preterm Infants: A Randomized Cross-Over Study / $c MEN. van den Heuvel, HA. van Zanten, TE. Bachman, AB. Te Pas, AH. van Kaam, W. Onland,
- 520 9_
- $a OBJECTIVE: To investigate the effect of different pulse oximetry (SpO2) target range settings during automated fraction of inspired oxygen control (A-FiO2) on time spent within a clinically set SpO2 alarm range in oxygen-dependent infants on noninvasive respiratory support. STUDY DESIGN: Forty-one preterm infants (gestational age [median] 26 weeks, age [median] 21 days) on FiO2 >0.21 receiving noninvasive respiratory support were subjected to A-FiO2 using 3 SpO2 target ranges (86%-94%, 88%-92%, or 89%-91%) in random order for 24 hours each. Before switching to the next target range, SpO2 was manually controlled for 24 hours (washout period). The primary outcome was the time spent within the clinically set alarm limits of 86%-94%. RESULTS: The percent time within the 86%-94% SpO2 alarm range was similar for all 3 A-FiO2 target ranges (74%). Time spent in hyperoxemia was not significantly different between target ranges. However, the time spent in severe hypoxemia (SpO2 <80%) was significantly reduced during the narrowed target ranges of A-FiO2 (88%-92%; 1.9%, 89%-91%; 1.7%) compared with the wide target range (86%-94%; 3.4%, P < .001). There were no differences between the 88%-92% and 89-91% target range. CONCLUSIONS: Narrowing the target range of A-FiO2 to the desired median ±2% is effective in reducing the time spent in hypoxemia, without increasing the risk of hyperoxemia. TRIAL REGISTRATION: www.trialregister.nl: NTR4368.
- 650 _2
- $a klinické alarmy $x statistika a číselné údaje $7 D056902
- 650 _2
- $a klinické křížové studie $7 D018592
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a novorozenec nedonošený $7 D007234
- 650 _2
- $a jednotky intenzivní péče o novorozence $7 D007363
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a neinvazivní ventilace $x metody $7 D063087
- 650 _2
- $a oxymetrie $x metody $7 D010092
- 650 _2
- $a kyslík $x krev $7 D010100
- 650 _2
- $a časové faktory $7 D013997
- 651 _2
- $a Nizozemsko $7 D009426
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 700 1_
- $a van Zanten, Henriette A $u Department of Pediatrics, Division of Neonatology, Leiden University Medical Center, Leiden, The Netherlands.
- 700 1_
- $a Bachman, Tom E $u Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic.
- 700 1_
- $a Te Pas, Arjan B $u Department of Pediatrics, Division of Neonatology, Leiden University Medical Center, Leiden, The Netherlands.
- 700 1_
- $a van Kaam, Anton H $u Department of Neonatology, Emma Children's Hospital, Academic Medical Center Amsterdam, The Netherlands.
- 700 1_
- $a Onland, Wes $u Department of Neonatology, Emma Children's Hospital, Academic Medical Center Amsterdam, The Netherlands.
- 773 0_
- $w MED00002885 $t The Journal of pediatrics $x 1097-6833 $g Roč. 197, č. - (2018), s. 36-41
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29571932 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190416075020 $b ABA008
- 999 __
- $a ok $b bmc $g 1392070 $s 1051065
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 197 $c - $d 36-41 $e 20180321 $i 1097-6833 $m The Journal of pediatrics $n J Pediatr $x MED00002885
- LZP __
- $a Pubmed-20190405